Browse Related Topics For:

Off-Label Promotion

115
Pharmaceutical Industry
108
FDA
73
First Amendment
60
Prescription Drugs
55
Off-Label Use
50
Amarin
46
FDCA
37
Medical Devices
32
Free Speech
31
Misbranding
29
False Claims Act (FCA)
25
Commercial Speech
21
Marketing
20
Preliminary Injunctions
18
Caronia
17
DOJ
17
Popular
15
FDA Approval
15
Healthcare
13
Settlement
12
Qui Tam
10
FDA Warning Letters
9
Physicians
9
Preemption
9
Whistleblowers
8
Enforcement Actions
8
Health Care Providers
8
SCOTUS
7
Failure To Warn
7
Life Sciences
7
Medicaid
7
Medicare
7
Product Labels
6
Anti-Kickback Statute
6
Compliance
6
Criminal Prosecution
6
Fraud
6
Kickbacks
5
Advertising
5
Draft Guidance
5
False Advertising
5
GlaxoSmithKline
5
Hospitals
5
Labeling
5
Relators
4
Abbott Laboratories
4
Allergan Inc
4
Class Action
4
Clinical Trials
4
Corporate Integrity Agreement
4
Criminal Conspiracy
4
Discovery
4
Dismissals
4
FCPA
4
Fifth Amendment
4
Financial Conduct Authority (FCA)
4
HHS
4
Injunctive Relief
4
Johnson & Johnson
4
Manufacturers
4
Pleading Standards
4
RICO
3
Acquittals
3
Administrative Procedure Act
3
Affordable Care Act
3
Amicus Briefs
3
Birth Defects
3
Class Certification
3
CMS
3
Corporate Counsel
3
Data Security
3
Enforcement
3
FFDCA
3
FTC
3
Generic Drugs
3
Indictments
3
InterMune
3
Misleading Statements
3
Misrepresentation
3
OIG
3
OPDP
3
Public Disclosure
2
3D Printing
2
510(k) RTA
2
Amended Regulation
2
ANDA
2
Anti-Competitive
2
Biosimilars
2
Causation
2
Celebrity Endorsements
2
Cephalon
2
Choice-of-Law
2
Civil Monetary Penalty
2
Comment Period
2
Commercial Marketing
2
Cybersecurity
2
Daubert Standards
2
Design Defects
2
Dietary Supplements
2
Due Process
2
FCC
2
Federal Question Jurisdiction
2
FTCA
2
Health Information Technologies
2
Insurance Industry
2
Interstate Commerce
2
Jury Verdicts
2
Kim Kardashian
2
Medicare Part D
2
Medtronic
2
Misleading Impressions
2
Motion to Amend
2
Negligence
2
Negligent Misrepresentation
2
Novartis
2
Orphan Drugs
2
Pending Legislation
2
Personal Liability
2
PHRMA
2
Precision Medicine Initiative (PMI)
2
Predominance Requirement
2
Product Defects
2
Proposed Amendments
2
Proposed Regulation
2
Public Health
2
Ripeness
2
Safe Harbors
2
SEC
2
Settlement Agreements
2
Strict Liability
2
Unfair or Deceptive Trade Practices
2
Warning Labels
2
Warning Letters
2
Wire Fraud
2
Yates Memorandum
1
21st Century Cures Initiative
1
AARP
1
Actual Injuries
1
Admissible Evidence
1
Alzheimer's
1
Amazon
1
Amgen Inc. v Connecticut Retirement Plans
1
Anti-Bribery
1
Anti-Corruption
1
Anti-Money Laundering
1
Appeals
1
Appellate Review
1
Arbitration
1
Arbitration Agreements
1
Article III
1
Attorney Generals
1
Audit Policies
1
Below-Cost Pricing
1
Bifurcation
1
Board of Directors
1
Botox
1
BPCIA
1
Brand
1
Breach of Warranty
1
Bribery
1
Bristol-Myers Squibb
1
Cancer
1
CEOs
1
CFPB
1
Chilling Effect
1
Clinical Laboratories
1
Compelled Speech
1
Compensation Standards
1
Compensatory Damages
1
Constructive Posession
1
Contingency Fees
1
Contract Drafting
1
Corporate Officers
1
Cost-Sharing
1
Cross-Border Transactions
1
Cyber Attacks
1
Cyber Insurance
1
D&O Insurance
1
Damages
1
Data Brokers
1
Data Privacy
1
Data Protection
1
De Novo Standard of Review
1
Declaratory Judgments
1
Declaratory Relief
1
Declination
1
Disclaimers
1
Dismissal With Prejudice
1
Dispute Resolution
1
Diversity Jurisdiction
1
DMEPOS
1
Do Not Disturb
1
Dodd-Frank
1
Drug Approvals
1
Durable Medical Equipment
1
Duty of Care
1
Duty to Defend
1
Electronic Records
1
Eleventh Amendment
1
Evidence
1
Ex Post Facto Clause
1
Expert Witness
1
Fair Notice
1
False Billing
1
False Statements
1
Federal Arbitration Act
1
Federal Register
1
Federal v State Law Application
1
FERA
1
First-to-File
1
Foreign Financial Accounts
1
Former Employee
1
Forum Non Conveniens
1
Fraud Abuse and Waste
1
Fraudulent Concealment
1
Fraudulent Joinder
1
Fraudulent Marketing
1
FTC v Actavis
1
Genuine Issue of Material Fact
1
Good Clinical Practices
1
Government Investigations
1
Grable Factors
1
GRAS
1
Guidance Update
1
Hackers
1
Health Insurance
1
Healthcare Facilities
1
Healthcare Fraud
1
Healthcare Reform
1
Hearsay
1
HEAT
1
Heightened Scrutiny
1
Hiring & Firing
1
Home Health Care
1
Honest Services Fraud
1
Hospice
1
HRSA
1
Humana
1
ICD-10
1
Illegal Gratuities
1
Individual Accountability
1
Inducements
1
Injunctions
1
Innovator Liability
1
Instagram
1
Intent of the Parties
1
International Arbitration
1
Investigational New Drug Application (IND)
1
Investment Trust Companies
1
Ireland
1
Israel
1
Janssen Pharmaceuticals
1
Jury Instructions
1
Jury Trial
1
Kaiser Permanente
1
KBR v ex rel Carter
1
Lanham Act
1
Law Practice Management
1
Leave to Amend
1
Legislative Committees
1
Letters Rogatory
1
Libor
1
Litigation Hold
1
Loss of Consortium
1
Mass Tort Litigation
1
Medicaid Expansion
1
Medicaid Reimbursements
1
Medicare Advantage
1
Merck
1
MLAT
1
Mobile Apps
1
Morgan Stanley
1
Motion to Compel
1
Motion to Dismiss
1
Motion to Remand
1
Multidistrict Litigation
1
Negligence Per Se
1
Negligent Infliction of Emotional Distress
1
Non-Compete Agreements
1
Northern Ireland
1
Nurses
1
Nursing Homes
1
Obama Administration
1
OMB
1
OMIG
1
Par Pharmaceutical
1
Patents
1
Patient Safety
1
Payday Loans
1
Penalties
1
Personal Jurisdiction
1
Personalized Medicine
1
Personally Identifiable Information
1
PF Chang's
1
Pfizer
1
Pharmacies
1
Physician Compensation Arrangements
1
Physician Medicare Reimbursements
1
Pleadings
1
PLIVA v Mensing
1
Policies and Procedures
1
Prescription Drug Coverage
1
Privacy Policy
1
Professional Liability
1
Public Health Insurance Marketplace
1
Punitive Damages
1
Putative Class Actions
1
Recordkeeping Requirements
1
Recruitment Policies
1
Reed v Town of Gilbert
1
Regulatory Agenda
1
Regulatory Standards
1
Remand
1
Removal
1
Required Documentation
1
Res Judicata
1
Retailers
1
Risk Management
1
Risk-Based Approaches
1
Rule 23
1
Rule 26
1
Salespersons
1
Sanctions
1
Sarbanes-Oxley
1
Schering-Plough
1
Sealed Records
1
Section 340B
1
Section 5
1
Securities Fraud
1
Self-Authentication
1
Self-Reporting
1
Shareholders
1
SNDAs
1
Social Media
1
Sovereign Immunity
1
Standing
1
State Law Tort Claims
1
Statute of Limitations
1
Stem cells
1
Strategic Enforcement Plan
1
Subpoenas
1
Summary Judgment
1
Takeda Pharmaceuticals
1
TCPA
1
Telemedicine
1
Third-Party
1
Tortious Interference
1
Trademarks
1
Travelers
1
TRICARE
1
Tuomey
1
U.S. Embassies
1
UK
1
USDA
1
Value-Based Purchasing
1
Visa Applications
1
Visas
1
Vouchers
1
Wage and Hour
1
White Collar Crimes
1
Workplace Safety
1
Wrongful Death
1
Zofran